In the media
February 16, 2022

On BBC Radio 5 Live, Owkin co-founder and CEO Thomas Clozel explains our new AI project to better detect HER2-positive breast cancer

Today our co-founder and CEO Thomas Clozel joined Naga Munchetty on B Radio to discuss our new project to develop hashtag#AI models to better detect HER2-positive breast cancer in women.

‍

About Owkin

Owkin is an agentic AI company on a mission to explore complex biology to speed up and scale research for the creation of new treatments and diagnostics for patients. Owkin K, our AI co-pilot combines unparalleled access to multimodal data, cutting-edge AI to quantify biology and pioneering agentic AI to achieve Biological Artificial Superintelligence in the future. 

Press Kit
More like this
In the media
EY features Owkin's CEO Thomas Clozel in the "Grow Fast, Now What?" podcast (FR)
February 18, 2025
Button
In the media
Les Echos covers Owkin’s role in AI in healthcare for the AI Action Summit
February 9, 2025
Button